These vaccines, developed by AstraZeneca, Novavax, and J&J,”are a little bit easier to scale up production at very low marginal costs,” Gates said.
The fact that two coronavirus vaccines recently showed strong protection against COVID-19 bodes well for other leading programs led by AstraZeneca, Novavax, and…







